Cadiele Oliana Reichert
Overview
Explore the profile of Cadiele Oliana Reichert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
20
Citations
273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Reichert C, Levy D, Maselli L, da Cunha J, Gualandro S, Bydlowski S
Antioxidants (Basel)
. 2025 Feb;
14(2).
PMID: 40002395
Antiretroviral therapy (ART) has significantly improved the life expectancy of people living with HIV-1 (PLWH). However, prolonged ART use is linked to metabolic alterations and oxidative stress. The paraoxonase (PON)...
2.
Nogueira D, Lage L, Reichert C, Culler H, de Freitas F, Mendes J, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682103
Clinical staging (CS) and tumor burden (TB) play a significant role in FL prognosis and direct its up-front therapy. The aim of this study is to report prognostic factors and...
3.
Oliveira B, Levy D, Paz J, de Freitas F, Reichert C, Rodrigues A, et al.
Int J Mol Sci
. 2024 Nov;
25(21).
PMID: 39518932
Some oxysterols were shown to promote osteogenic differentiation of mesenchymal stem cells (MSCs). Little is known about the effects of 7-ketocholesterol (7-KC) in this process. We describe its impact on...
4.
de Freitas F, Levy D, Reichert C, Sampaio-Silva J, Giglio P, Lage L, et al.
Int J Mol Sci
. 2024 May;
25(9).
PMID: 38731966
Leukemias are among the most prevalent types of cancer worldwide. Bone marrow mesenchymal stem cells (MSCs) participate in the development of a suitable niche for hematopoietic stem cells, and are...
5.
Lage L, De Vita R, Alves L, Jacomassi M, Culler H, Reichert C, et al.
Cancers (Basel)
. 2024 Apr;
16(8).
PMID: 38672542
Background: Diffuse large B-cell lymphoma (DLBCL) especially affects the older population. Old (≥60 years) and very old age (≥80 years) DLBCL patients often present high-risk molecular alterations, lower tolerability to...
6.
Jardini M, Pedroso J, Ferreira C, Nunes C, Reichert C, Aldin M, et al.
Clin Oral Investig
. 2024 Jan;
28(1):80.
PMID: 38183505
Objectives: Subgingival instrumentation (SI) with probiotics may be a proposal for the treatment of periodontitis (P), for patients with type 2 diabetes mellitus (T2DM). The Lactobacillus reuteri probiotic as an...
7.
Lage L, Elias M, Reichert C, Culler H, de Freitas F, Costa R, et al.
Cancers (Basel)
. 2023 Oct;
15(19).
PMID: 37835453
Background: Mantle cell lymphoma (MCL) is a rare malignancy with heterogeneous behavior. Despite the therapeutic advances recently achieved, MCL remains incurable. Currently, the standard of care for young and fit...
8.
Lage L, Culler H, Reichert C, da Siqueira S, Pereira J
Front Oncol
. 2023 May;
13:1177590.
PMID: 37182145
Angioimmunoblastic T-cell lymphoma (AITL) is the second most frequent subtype of mature T-cell lymphoma (MTCL) in the Western world. It derives from the monoclonal proliferation of T-follicular helper (TFH) cells...
9.
Lage L, Culler H, Barreto G, Reichert C, Levy D, Costa R, et al.
Clin Epigenetics
. 2022 Dec;
14(1):180.
PMID: 36536430
Nodal mature T-cell lymphomas (nMTCL) comprises a heterogeneous group of rare malignancies with aggressive biological behavior and poor prognosis. Epigenetic phenomena, including mutations in genes that control DNA methylation and...
10.
Lage L, Machado P, Reichert C, Miranda E, Culler H, da Siqueira S, et al.
Sci Rep
. 2022 Nov;
12(1):20557.
PMID: 36446856
Extranodal natural-killer/T-cell lymphoma (ENKTL) is a rare and aggressive Epstein-Barr virus related mature T-cell and natural-killer malignancy. Although highly prevalent in South America, few studies covering data from this geographic...